InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-24.2%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Grove Robert Earle, 董事. Director active across 1 company, notably IRIDEX CORP. Aggregated, 4 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 16 June 2021. The latest transaction was filed on 14 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Grove Robert Earle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
39,267 股@ US$1.9179.7% 占其流量Common StockSEC:0001209191-23-037565:0
27,472 股0Common StockSEC:0001209191-22-037550:0
1,644 股@ US$6.08211.3% 占其流量Common StockSEC:0001209191-21-067672:0
标准退出：2022年3月2日 (T+90)
5,420 股0Common StockSEC:0001209191-21-042265:0
4 条申报中的 4 条
About Grove Robert Earle
Grove Robert Earle is a Board Member at IRIDEX CORP. He brings valuable expertise in the medical field, contributing to the strategic direction of the company. His role includes overseeing operations and commitment to best governance practices.
